Skip to main content

Topic

Cannabinoids

61 published works

  1. Canna Law Blog

    Congress Wants to Hear from You on CBD by August 18th

    By Vince Sliwoski

    Today’s public service announcement is that Congress wants to hear from you on a regulatory fix for cannabidiol (CBD) and other hemp-derived cannabinoid products. The request came down via the…

  2. Canna Law Blog

    Cannabinoid Folks, Pay Attention to Kratom

    By Griffen Thorne

    It seems as if there is a new cannabinoid product coming out every five minutes. Scratch that – it seems like there is a new cannabinoid coming out every five minutes.…

  3. Tobacco Law Blog

    Virginia’s New Hemp Regulations – How It Affects Businesses

    By Christina Sava, Agustin Rodriguez, Kevin Andres Rodriguez

    Virginia's new hemp-derived products statutes (Va. Code § 3.2-5145.1 et seq.) went into effect as of July 1, standing to drastically alter the availability of hemp-derived products in Virginia. What…

  4. Canna Law Blog

    So Long for THCA Products

    By Griffen Thorne

    Ever since Congress passed the Agricultural Improvements Act of 2018 (or 2018 Farm Bill), people have tried to find creative ways to sell intoxicating hemp-derived products. One example of this…

  5. Kight on Cannabis

    Did New York’s Office of Cannabis Management Just Overreach on Hemp Cannabinoids?

    By Rod Kight

    Although the New York Cannabis Control Board is permitted by law to prohibit certain products or classes of products derived from cannabinoid hemp, it remains unclear how it would prohibit "high THC…

  6. Kight on Cannabis

    How Is This Not Hemp? Peeking Under the Hood at a THCa Hemp Flower Production Facility

    By Rod Kight

    THCa Flower remains misunderstood and controversial. For that reason, I took to the field, literally and figuratively, and toured a THCa Flower production facility in my home state of North Carolina.

  7. Budding Trends

    Editors’ Roundtable: Predictions About the Upcoming Farm Bill

    By Whitt Steineker, James W. Wright Jr., J. Hunter Robinson, Slates C. Veazey

    Welcome to the latest installment of the Editors’ Roundtable, in which our editors – Whitt Steineker, Jay Wright, Hunter Robinson, and Slates Veazey – discuss cannabis issues in the news and take a stab at…

  8. Kight on Cannabis

    Rod Discusses Minor Cannabinoids and the DEA [Video]

    By Rod Kight

    This post contains the full-length video discussion I recently had about novel cannabinoids and the DEA with Christopher Ware, founder of KCA Laboratories, and Jody McGinness, Executive Director of the…

  9. Cannabis Legal Highlights

    Cannabis Legal Report—Week of March 1, 2023

    By Elizabeth Gustafson, Tommy Tobin, Andrew Kline, Hanna Barker Mullin

    Cannabis: In Focus DEA Classifies Two Lab-Derived Cannabinoids as Schedule I Washington Federal Judge Dismisses Suit Challenging Residency Requirements DEA Classifies Two Lab-Derived Cannabinoids as Schedule I The U.S. Drug…

  10. Kight on Cannabis

    Cannabinoid Breakdown- Analyzing the DEA’s Position on Novel Cannabinoids

    By Rod Kight

    This article breaks down the legal status of novel and mood-altering cannabinoids, including a discussion of the “synthetic versus natural” issue that is dominating much of the cannabis conversation in…